This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: University Of Louisville Research Foundation, Inc., Other. Active years: 2011-2013.
Company Filing History:
1 out of 398 
1 out of 834,350 Years Active: 2011-2013
Title: Nalini S Bora: Innovator in Neovascularization and Age-Related Macular Degeneration
Introduction
Nalini S Bora is a prominent inventor based in Little Rock, AR (US). She has made significant contributions to the field of medical research, particularly in the areas of neovascularization and age-related macular degeneration (AMD). With a total of 2 patents, her work has the potential to impact the treatment of various ocular conditions.
Latest Patents
Nalini S Bora's latest patents include innovative methods aimed at addressing critical health issues. One patent describes a "Method of inducing neovascularization," which involves injecting a pharmaceutically effective amount of polyethylene glycol (PEG) into tissue to accelerate wound healing and mimic conditions such as age-related macular degeneration, cancer, tumors, and atherosclerosis for further research purposes. Another significant patent focuses on the "Inhibition of wet type age-related macular degeneration (AMD) by adiponectin or acrp 30." This invention provides new methods for treating wet AMD by administering adiponectin or its functional fragments, demonstrating the inhibitory effect of adiponectin on choroidal angiogenesis.
Career Highlights
Throughout her career, Nalini S Bora has worked with various institutions, including the University of Louisville Research Foundation, Inc. Her research has garnered attention for its innovative approaches to treating complex medical conditions.
Collaborations
Nalini has collaborated with notable individuals in her field, including Puran S Bora and Henry J Kaplan. These partnerships have contributed to the advancement of her research and the development of her patents.
Conclusion
Nalini S Bora's contributions to the field of medical research, particularly in neovascularization and age-related macular degeneration, highlight her role as an influential inventor. Her innovative patents pave the way for new treatment options and further research in these critical areas.